Document Detail


Erythropoietin receptor and hematological disease.
MedLine Citation:
PMID:  9883806     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review will discuss evidence for the role of the erythropoietin (Epo) receptor in the development of erythrocytosis and other hematological disorders. The possible causative role of mutations of other genes in the pathogenesis of idiopathic erythrocytosis will be considered. Polycythemia vera (PV) is a myeloproliferative disorder that is caused by an undefined stem cell abnormality, characterized by a significant erythrocytosis, leukocytosis, and thrombocytosis. However, erythrocytosis may arise from apparent (or relative) polycythemia in which the hematocrit is raised due to a low plasma volume. In such cases the red cell mass is normal. A group of disorders with increased red cell mass caused by stimulation of erythrocyte production is known as secondary polycythemia. Investigation of such patients may reveal a congenital abnormality such as high affinity hemoglobin or an acquired abnormality caused, for example, by smoking, renal vascular impairment, or an Epo-producing tumor. Even after thorough examination there remains a cohort of patients for whom no definite cause for the erythrocytosis can be established. A careful clinical history may reveal whether this idiopathic erythrocytosis is likely to be congenital and/or familial, in which case the term "primary familial and congenital polycythemia" is sometimes applied. Access to a range of laboratory investigations may define the molecular pathophysiology. We will now discuss how this process can be investigated.
Authors:
M F McMullin; M J Percy
Related Documents :
22841686 - Parkinson disease: associated disorders in the norwegian population based incident park...
22373296 - Classification of bipolar disorder in psychiatric hospital. a prospective cohort study.
22774456 - The spanish validation of level of expressed emotion scale for relatives of people with...
1474486 - Maffucci's syndrome. review of the literature and case report.
9698986 - Early adolescent gateway drug use in sons of fathers with substance use disorders.
23017486 - Depressive comorbidity in personality disorders.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  American journal of hematology     Volume:  60     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-01-27     Completed Date:  1999-01-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  55-60     Citation Subset:  IM    
Affiliation:
Department of Haematology, The Queen's University of Belfast, The Royal Victoria Hospital, Northern Ireland. M.McMullin@qub.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Hematologic Diseases / physiopathology*
Humans
Receptors, Erythropoietin / physiology*
Chemical
Reg. No./Substance:
0/Receptors, Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factor XI deficiency in women.
Next Document:  Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome.